Anlon Healthcare Ltd
Anlon Healthcare | 544497
AHCL - Share Price Chart
Stock Performance
Ratios
Consolidated data not available
Please try selecting a different data type
About Company
- Anlon Healthcare Limited was originally incorporated as 'Anlon Ventures Private Limited', dated November 19, 2013 issued by the RoC
- The Company changed the name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh Certificate of Incorporation dated May 27, 2015 was issued by the RoC
- The status of the Company was subsequently converted to a Public Limited and the name of the Company was changed to 'Anlon Healthcare Limited' dated September 2, 2024 by the RoC
- Anlon Healthcare is engaged in manufacturing of Pharma Intermediates and APIs
- They are one of the few manufacturers of loxoprofen sodium dihydrate in India, a notable API , widely used in treatment of pain/inflammation association with conditions including rheumatoid arthritis, osteoarthritis, lower back pain, frozen shoulder, neck-shoulder-arm syndrome, tooth pain or after surgery, injury or tooth extraction
- It serves as a raw material for pharmaceutical formulations in preparation of various type of Finished Dosage Formula (FDF) such as tablet, capsules, ointment, syrup etc, ingredients in nutraceuticals formulations, personal care products and animal health products
- In addition to manufacturing of Pharma Intermediate and APIs in accordance with various domestic and international standards, the Company has recently started undertaking custom manufacturing services for complex or novel chemical compounds
- The Company started commercial production of Pharma Intermediate and API in 2018
- It work out manufacturing activities at Rajkot, Gujarat, which comprise of two separate manufacturing blocks for manufacturing of Pharmaceutical Intermediate and APIs respectively with an aggregate installed production capacity of 400 MTPA
- The Company launched the Initial Public Offering of 1,33,00,000 equity shares having the face value of Rs 10, by raising funds aggregating to Rs 121
Research Calls
Technical Indicators
Pivot Points
Volume Analysis
No Information Available
Growth Rate information is not available at this time.
All figures in ₹ Crores
No Information Available
No profit & lossdata available
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Top Gainers
Top Losers
Group Stocks
Frequently Asked Questions
What is Share Price of Anlon Healthcare Ltd?
The current share price of Anlon Healthcare Ltd (Anlon Healthcare) is ₹14.28. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Anlon Healthcare Ltd?
The Price-to-Earnings (P/E) ratio of Anlon Healthcare Ltd is 14.28. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Anlon Healthcare Ltd?
Anlon Healthcare Ltd has a 52-week high of ₹17.28 and a 52-week low of ₹9.08. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Anlon Healthcare Ltd?
Anlon Healthcare Ltd offers a dividend yield of 0.00%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Anlon Healthcare Ltd?
The Earnings Per Share (EPS) of Anlon Healthcare Ltd is ₹0.60. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Anlon Healthcare Ltd?
Anlon Healthcare Ltd has a Return on Equity (ROE) of 40.45%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
